Accueil / Tag Archives: Infectious Diseases (page 3)

Tag Archives: Infectious Diseases

Azitra Completes $14 Million Series A Financing

Tuesday, October 15th 2019 at 1:02pm UTC -Funding to support management team expansion and advancement to the clinic- FARMINGTON, Conn.–(BUSINESS WIRE)– Azitra Inc., a clinical-stage medical dermatology company addressing serious skin conditions by harnessing the microbiome, today announced that it has closed a $14 million Series A financing. The financing …

Plus »

2019 France Nucleic Acid Testing/NAT Market for 100 Assays: Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing – ResearchAndMarkets.com

Friday, October 11th 2019 at 1:35pm UTC DUBLIN–(BUSINESS WIRE)– The « France Nucleic Acid Testing/NAT Market for 100 Assays: Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts-Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing » report has been added to ResearchAndMarkets.com’s offering. This new 1,125-page report from the author …

Plus »

Enzo Biochem Schedules Teleconference to Discuss Fourth Quarter and Fiscal Year 2019 Results Tuesday, October 15, 2019 at 4:30 PM E.T.

Friday, October 11th 2019 at 1:00pm UTC NEW YORK–(BUSINESS WIRE)– Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2019 fourth quarter and fiscal year 2019 results on Tuesday, October 15, 2019, at 4:30 PM E.T. To listen to the conference call dial 1-888-459-5609. International callers can …

Plus »

Pharm-Olam Appoints Dr. Robert Davie as Chief Executive Officer

Wednesday, October 9th 2019 at 12:00pm UTC Davie Succeeds David Grange, Positioning Organization for Continued Growth HOUSTON–(BUSINESS WIRE)– Pharm-Olam, a global midsized CRO, today announced that the company’s board of directors has elected Robert Davie, Ph.D., as its new chief executive officer. Pharm-Olam provides full-service clinical development solutions for oncology-hematology, …

Plus »

Novodiag® Stool Parasites : un test moléculaire exhaustif et rapide pour la détection des infections gastro-intestinales

Wednesday, October 9th 2019 at 6:00am UTC ESPOO, Finlande–(BUSINESS WIRE)– Mobidiag Ltd. société de diagnostic moléculaire dotée de plateformes complémentaires qui répondent aux problématiques liées à la résistance aux antimicrobiens et autres besoins diagnostiques non satisfaits; annonce aujourd’hui le marquage CE-IVD du test Novodiag® Stool Parasites. Il s’agit d’un test …

Plus »

Gilead and Galapagos Announce Efficacy and Safety Results of Filgotinib Through 52 Weeks in FINCH 1 and FINCH 3 Studies in Rheumatoid Arthritis

Thursday, October 10th 2019 at 10:00pm UTC FOSTER CITY, Calif. & MECHELEN, Belgium–(BUSINESS WIRE)– Gilead Sciences, Inc. (NASDAQ: GILD) and Galapagos NV (Euronext & NASDAQ: GLPG) today announced that Week 52 data from the registrational Phase 3 FINCH 1 and FINCH 3 trials of filgotinib, an investigational, oral, selective JAK1 …

Plus »

Molecular Diagnostics,Technologies & Companies Market, Forecast to 2028 – ResearchAndMarkets.com

Wednesday, October 9th 2019 at 12:23pm UTC DUBLIN–(BUSINESS WIRE)– The « Molecular Diagnostics – Technologies, Markets and Companies » report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This report describes and evaluates the molecular diagnostics technologies that will play an important role in the practice of medicine, public health, pharmaceutical …

Plus »

New Novodiag® Stool Parasites Test Allows Rapid, Accurate and Cost-effective Molecular Testing for Gastrointestinal Infections

Wednesday, October 9th 2019 at 6:00am UTC ESPOO, Finland–(BUSINESS WIRE)– Mobidiag Ltd., a revenue generating, molecular diagnostics company with complementary platforms that address antimicrobial resistance and other areas of unmet diagnostic need, today announces the CE-IVD marking of the Novodiag® Stool Parasites test, a comprehensive and cost-effective molecular diagnostic test …

Plus »

BioNTech Announces Pricing of Initial Public Offering

Thursday, October 10th 2019 at 7:16am UTC MAINZ, Germany–(BUSINESS WIRE)– BioNTech SE (“BioNTech”), a clinical-stage biotechnology company focused on patient-specific immunotherapies for the treatment of cancer and other serious diseases, today announced the pricing of its initial public offering of 10,000,000 American Depositary Shares (“ADSs”) representing 10,000,000 ordinary shares at …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.